Comera Life Sciences Holdings, Inc.Comera Life Sciences Holdings, Inc.Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

No trades
Market capitalization
‪3.07 K‬USD
‪4.37 M‬
Beta (1Y)
0.00

About Comera Life Sciences Holdings, Inc.


CEO
Michael Campbell
Headquarters
Woburn
Founded
2022
Identifiers
3
ISIN US20037C1163
Comera Life Sciences Holdings, Inc. engages in developing medicines. It applies a deep knowledge of formulation science and technology to transform essential biologic medicines. The firm's approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen. The company was founded on January 31, 2022 and is headquartered in Woburn, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.